Pharma Integrates Agenda 2022
BIG HEALTH
How do we tackle some of the biggest health challenges, such as chronic conditions, respiratory and cancer? Â
TECHNOLOGY
How can we use technology to improve health outcomes, improve sustainability and create robust supply chains? Â
ENABLERS
How do we enable a better Industry, through creating diverse skilled teams, empowering the patient and navigating the economic and regulatory environment? Â
Registration and Networking
08:00 – 08:50
Registration and Networking
Welcome & Opening Remarks
Room 1
08:50 – 09:00
Fireside Chat
Room 1
09:00 – 09:20
Fireside Chat
TIM FERRISÂ | National Director of Transformation | NHS England and NHS Improvement
Interviewed by
JENNY OUSBEYÂ | Chief Executive Officer & Founder | Ovid Health
Fireside Chat
Room 1
09:20 – 09:40
Fireside Chat
LORD DAVID PRIORÂ | Deputy Chairman UK and Global Senior Advisor | Lazard
Interviewed by
TAMSIN BERRY | Head of Policy and Partnerships, AreteiaTx | Partner, Population Health Partners
Session 1
09:45 – 10:35
Rise of the centenarians
An industry is forming around human longevity to treat age-related diseases and extend our lives. What does this mean for Pharma? How do we tackle age-related diseases like dementia?
Formulating the future
There is a pressure to speed up time to market, but what can drug development scientists do to speed up this important stage?
Patients in charge
How should we engage and empower patients in their healthcare journeys?
Coffee Break
10:35 – 11:10
Networking coffee break
Session 2
11:15 – 12:05
Take a breatherÂ
Asthma affects 5.4 million in the UK. Tragically, four people die every day because of asthma attacks. A major study into asthma deaths (the National Review of Asthma Deaths 2014) found that two-thirds of asthma deaths are preventable.
Go Green!
The UK has committed to reduce its greenhouse-gas emissions to net zero by 2050. What is the Industry doing to support this?
Vive la difference
What is the evidence that we need to have more diverse and inclusive organisations?
How do we harness the diversity we know brings better business results?
What are the challenges in bringing diverse individuals together and how do we overcome them?
Session 3
12:10 – 13:00
Dare to think rare
The advancements in breakthrough therapies, such as cell and gene therapies, over the past few decades has been exponential, but how do we increase access for patients with rare diseases?
Detect. Inspect. HealthTech.
Innovations around Covid-19 changed the MedTech landscape, but are those learnings being adopted for other conditions? How are drug devices converging with digital?
Please join Track 1 or 2
Please join Track 1 or 2
Lunch Break
13:00 – 14:05
Networking lunch break
Session 4
14:05 – 14:55
The Big ‘C’
As Europe’s population gets older, the number of people being diagnosed with cancer could increase by up to 18% in 2040. Advances in prevention, early detection, diagnosis and treatments are improving patient outcomes, but there is still a lot more to do.
Signed Sealed Delivered
How is technology enabling an efficient and robust supply chain?
Consumers, treatments and health systems are changing – can truly disruptive innovation in healthcare supply chains meet these needs?
Are you in or out sourcing?
What is the strategic role of the CDMO and CRO? How has partnering changed?
Session 5
15:00 – 15:50
Please join Track 2 or 3
Please join Track 2 or 3
Artificial Intelligence – hype, hope or happening?
AI is being applied to drug discovery, development, diagnosis and supply chains. How successful has it been so far? What does the future hold?
Trials and tribulations
What are the latest innovations in clinical trials? How are this being adopted?
Closing Remarks
Bar Area
15:50 – 16:00
Closing Remarks
TREVOR JONES | Chairman, e-Therapeutics and Board Member, Respiratory Innovation Wales and Ascension Healthcare
Drinks Reception
16:00 – 16:50
Networking drinks reception
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.
Pharma Integrates Agenda 2022
Registration and Networking
08:00 – 08:50
Welcome & Opening Remarks
Room 1
08:50 – 09:00
Susan Rienow, Country President UK, Pfizer & Vice President ABPI
Fireside Chat
Room 1
09:00 – 09:20
TIM FERRISÂ | National Director of Transformation | NHS England and NHS Improvement
Interviewed by
JENNY OUSBEYÂ | Chief Executive Officer & Founder | Ovid Health
Fireside Chat
Room 1
09:20 – 09:40
LORD DAVID PRIORÂ | Deputy Chairman UK and Global Senior Advisor | Lazard
Interviewed by
TAMSIN BERRYÂ | Head of Policy and Partnerships, AreteiaTx | Partner, Population Health Partners
BIG HEALTH
How do we tackle some of the biggest health challenges, such as chronic conditions, respiratory, cancer and antimicrobial resistance? Â
SESSION 1
09:45 – 10:35
Rise of the centenarians
An industry is forming around human longevity to treat age-related diseases and extend our lives. What does this mean for Pharma? How do we tackle age-related diseases like dementia?
Coffee Break
10:35 – 11:10
SESSION 2
11:15 – 12:05
Take a breatherÂ
Asthma affects 5.4 million in the UK. Tragically, four people die every day because of asthma attacks. A major study into asthma deaths (the National Review of Asthma Deaths 2014) found that two-thirds of asthma deaths are preventable. Join us for a session that explores the recent technological advances in asthma treatments, the latest research agenda and policies to overcome the burden of this disease.
SESSION 3
12:10 – 13:00
Dare to think rare
The advancements in breakthrough therapies, such as cell and gene therapies, over the past few decades has been exponential, but how do we increase access for patients with rare diseases?
Lunch Break
13:00 – 14:05
SESSION 4
14:05 – 14:55
The Big ‘C’
As Europe’s population gets older, the number of people being diagnosed with cancer could increase by up to 18% in 2040. Advances in prevention, early detection, diagnosis and treatments are improving patient outcomes, but there is still a lot more to do.
SESSION 5
15:00 – 15:50
Please join Track 2 or 3
Please join Track 2 or 3
Closing Remarks
Bar Area
15:50 – 16:00
TREVOR JONES | Chairman, e-Therapeutics and Board Member, Respiratory Innovation Wales and Ascension Healthcare
Drinks Reception
16:00 – 16:50
TECHNOLOGY
How can we use technology to improve health outcomes, improve sustainability and create robust supply chains? Â
SESSION 1
09:45 – 10:35
Formulating the future
There is a pressure to speed up time to market, but what can drug development scientists do to speed up this important stage?
Coffee Break
10:35 – 11:10
SESSION 2
11:15 – 12:05
Go Green!
The UK has committed to reduce its greenhouse-gas emissions to net zero by 2050. What is the Industry doing to support this?
SESSION 3
12:10 – 13:00
Detect. Inspect. HealthTech.
Innovations around Covid-19 changed the MedTech landscape, but are those learnings being adopted for other conditions? How are drug devices converging with digital?
Lunch Break
13:00 – 14:05
SESSION 4
14:05 – 14:55
Signed Sealed Delivered
How is technology enabling an efficient and robust supply chain?
Consumers, treatments and health systems are changing – can truly disruptive innovation in healthcare supply chains meet these needs?
How do corporates and start-ups collaborate to effect that change at pace?
SESSION 5
15:00 – 15:50
Artificial Intelligence – hype, hope or happening?
AI is being applied to drug discovery, development, diagnosis and supply chains. How successful has it been so far? What does the future hold?
Closing Remarks
Bar Area
15:50 – 16:00
TREVOR JONES | Chairman, e-Therapeutics and Board Member, Respiratory Innovation Wales and Ascension Healthcare
Drinks Reception
16:00 – 16:50
ENABLERS
How do we enable a better Industry, through creating diverse skilled teams, empowering the patient and navigating the economic and regulatory environment? Â
SESSION 1
09:45 – 10:35
Patients in charge
How should we engage and empower patients in their healthcare journeys?
Coffee Break
10:35 – 11:10
SESSION 2
11:15 – 12:05
Vive la difference
What is the evidence that we need to have more diverse and inclusive organisations?
How do we harness the diversity we know brings better business results?
What are the challenges in bringing diverse individuals together and how do we overcome them?
SESSION 3
12:10 – 13:00
Play by the rules
New regulations have been put in place by the MHRA to speed up getting drugs to market, but are they making a difference? Does the commercial side add up?
Lunch Break
13:00 – 14:05
SESSION 4
14:05 – 14:55
Are you in or out sourcing?
What is the strategic role of the CDMO and CRO? How has partnering changed?
SESSION 5
15:00 – 15:50
Trials and tribulations
What are the latest innovations in clinical trials? How are this being adopted?
Closing Remarks
Bar Area
16:00 – 16:00
TREVOR JONES | Chairman, e-Therapeutics and Board Member, Respiratory Innovation Wales and Ascension Healthcare
Drinks Reception
15:50 – 16:50
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.